Pathology News
From Proscia on LinkedIn When evaluating an enterprise pathology platform, many life sciences organizations and diagnostic laboratories focus on the features it offers. This makes sense since scientists and pathologists will rely on that...
Nucleai, Gilead, and target-positive tumors Antibody-drug conjugates (ADCs) have emerged as one of the busiest and most crowded niches within oncology, given their potential to use an antibody to ferry a potent cytotoxic payload toward...
aetherAI: Delivering Integrated Software-and-Hardware Consulting Solutions for the Global Digital Transformation of Pathology — Growth Momentum Poised to Accelerate aetherAI (7803), a global leader in digital pathology and AI healthcare...
The partnership brings elea’s pathology-specific AI directly into Techcyte Fusion, enabling pathologists to turn assessments into structured, coded reports. OREM, UT, UNITED STATES, August 13, 2026 /EINPresswire.com/ -- Techcyte today...
From Smart In Media: Scanners, image management systems and AI are transforming pathology. Yet one critical step often remains disconnected from the digital workflow: the grossing station. Gross images may be captured separately, named...
From the Proscia blog: Interoperability in digital pathology is about more than the ability to open an image file. It means giving pathologists a consistent, trusted experience as laboratories add scanners, displays, and connected systems....
